“Not only is this reform a game-changer for Australian patients, but it truly showcases the Australian Government’s commitment in empowering patients with more knowledge and a better understanding of their medicines. This is of key importance in the current COVID-19 environment,” said GBMA chair Jane Halton AO PSM.
GBMA's says active ingredient prescribing a 'game-changer' for patients
February 1, 2021 Latest NewsBioPharma
Latest Video
New Stories
-
This exchange on the HTA Review was about as underwhelming as it sounds
October 9, 2025 - - Latest News -
AusBiotech unveils international conference program for Australia’s biggest week in biotech
October 9, 2025 - - Australian Biotech -
Life sciences industry calls for stronger national strategy to support trials and innovation
October 9, 2025 - - Latest News -
Officials outline ongoing measures to address ADHD medicine shortages
October 9, 2025 - - Latest News -
Pharmaceutical spending to rise by around $10 billion, but still lose ground to other programs
October 9, 2025 - - Latest News -
Australian company reports positive outcome from collaboration
October 8, 2025 - - Australian Biotech -
CUREator opens $33 million funding round with CSL and AbbVie partnership
October 8, 2025 - - Latest News